West Pharmaceutical Services, Inc. (WST)
USD 211.29
(0.49%)
USD 211.29
(0.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 157.3 Million USD | -47.51% |
| 2022 | 299.7 Million USD | 10.26% |
| 2021 | 271.8 Million USD | -13.25% |
| 2020 | 313.3 Million USD | -1.29% |
| 2019 | 317.4 Million USD | 61.94% |
| 2018 | 196 Million USD | -0.51% |
| 2017 | 197 Million USD | -12.91% |
| 2016 | 226.2 Million USD | -1.18% |
| 2015 | 228.9 Million USD | -26.04% |
| 2014 | 309.5 Million USD | -16.64% |
| 2013 | 371.3 Million USD | -1.98% |
| 2012 | 378.8 Million USD | 26.56% |
| 2011 | 299.3 Million USD | -16.42% |
| 2010 | 358.1 Million USD | -5.54% |
| 2009 | 379.1 Million USD | -0.79% |
| 2008 | 382.1 Million USD | -3.17% |
| 2007 | 394.6 Million USD | 67.35% |
| 2006 | 235.8 Million USD | -16.0% |
| 2005 | 280.7 Million USD | 86.14% |
| 2004 | 150.8 Million USD | -9.7% |
| 2003 | 167 Million USD | 4.9% |
| 2002 | 159.2 Million USD | -13.62% |
| 2001 | 184.3 Million USD | -5.87% |
| 2000 | 195.8 Million USD | 38.37% |
| 1999 | 141.5 Million USD | 34.76% |
| 1998 | 105 Million USD | 20.14% |
| 1997 | 87.4 Million USD | -8.48% |
| 1996 | 95.5 Million USD | -8.61% |
| 1995 | 104.5 Million USD | 191.09% |
| 1994 | 35.9 Million USD | 45.93% |
| 1993 | 24.6 Million USD | -21.9% |
| 1992 | 31.5 Million USD | -35.85% |
| 1991 | 49.1 Million USD | -25.83% |
| 1990 | 66.2 Million USD | 27.06% |
| 1989 | 52.1 Million USD | 6.76% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 202.6 Million USD | 177.91% |
| 2024 Q1 | 155.2 Million USD | 0.0% |
| 2024 Q2 | 72.9 Million USD | 0.14% |
| 2023 Q2 | 292.9 Million USD | -1.05% |
| 2023 FY | 157.3 Million USD | -47.51% |
| 2023 Q1 | 296 Million USD | -1.23% |
| 2023 Q3 | 235.1 Million USD | -19.73% |
| 2023 Q4 | 157.3 Million USD | -33.09% |
| 2022 Q1 | 277.2 Million USD | 1.99% |
| 2022 FY | 299.7 Million USD | 10.26% |
| 2022 Q4 | 299.7 Million USD | 5.38% |
| 2022 Q3 | 284.4 Million USD | 2.3% |
| 2022 Q2 | 278 Million USD | 0.29% |
| 2021 FY | 271.8 Million USD | -13.25% |
| 2021 Q4 | 271.8 Million USD | 3.23% |
| 2021 Q3 | 263.3 Million USD | -14.46% |
| 2021 Q2 | 307.8 Million USD | -0.61% |
| 2021 Q1 | 309.7 Million USD | -1.15% |
| 2020 Q4 | 313.3 Million USD | 0.0% |
| 2020 Q1 | 315.6 Million USD | -0.57% |
| 2020 Q3 | 313.3 Million USD | -0.48% |
| 2020 Q2 | 314.8 Million USD | -0.25% |
| 2020 FY | 313.3 Million USD | -1.29% |
| 2019 Q4 | 317.4 Million USD | 22.74% |
| 2019 FY | 317.4 Million USD | 61.94% |
| 2019 Q1 | 262.9 Million USD | 34.13% |
| 2019 Q2 | 262.4 Million USD | -0.19% |
| 2019 Q3 | 258.6 Million USD | -1.45% |
| 2018 Q4 | 196 Million USD | -0.1% |
| 2018 Q2 | 196.4 Million USD | -0.81% |
| 2018 Q3 | 196.2 Million USD | -0.1% |
| 2018 Q1 | 198 Million USD | 0.51% |
| 2018 FY | 196 Million USD | -0.51% |
| 2017 Q2 | 195.7 Million USD | 0.77% |
| 2017 FY | 197 Million USD | -12.91% |
| 2017 Q4 | 197 Million USD | 0.2% |
| 2017 Q3 | 196.6 Million USD | 0.46% |
| 2017 Q1 | 194.2 Million USD | -14.15% |
| 2016 Q2 | 228.9 Million USD | -0.26% |
| 2016 FY | 226.2 Million USD | -1.18% |
| 2016 Q4 | 226.2 Million USD | -1.05% |
| 2016 Q3 | 228.6 Million USD | -0.13% |
| 2016 Q1 | 229.5 Million USD | 0.26% |
| 2015 FY | 228.9 Million USD | -26.04% |
| 2015 Q2 | 231.7 Million USD | -0.09% |
| 2015 Q1 | 231.9 Million USD | -25.07% |
| 2015 Q4 | 228.9 Million USD | -1.12% |
| 2015 Q3 | 231.5 Million USD | -0.09% |
| 2014 Q2 | 359.3 Million USD | -8.04% |
| 2014 FY | 309.5 Million USD | -16.64% |
| 2014 Q4 | 309.5 Million USD | -1.9% |
| 2014 Q1 | 390.7 Million USD | 5.22% |
| 2014 Q3 | 315.5 Million USD | -12.19% |
| 2013 FY | 371.3 Million USD | -1.98% |
| 2013 Q3 | 381.1 Million USD | -3.45% |
| 2013 Q2 | 394.7 Million USD | -7.87% |
| 2013 Q1 | 428.4 Million USD | 13.09% |
| 2013 Q4 | 371.3 Million USD | -2.57% |
| 2012 FY | 378.8 Million USD | 26.56% |
| 2012 Q4 | 378.8 Million USD | 4.61% |
| 2012 Q3 | 362.1 Million USD | 22.17% |
| 2012 Q2 | 296.4 Million USD | 0.51% |
| 2012 Q1 | 294.9 Million USD | -1.47% |
| 2011 Q3 | 323.3 Million USD | -11.96% |
| 2011 Q1 | 364.7 Million USD | 1.84% |
| 2011 Q4 | 299.3 Million USD | -7.42% |
| 2011 FY | 299.3 Million USD | -16.42% |
| 2011 Q2 | 367.2 Million USD | 0.69% |
| 2010 FY | 358.1 Million USD | -5.54% |
| 2010 Q1 | 348.3 Million USD | -8.12% |
| 2010 Q2 | 356.8 Million USD | 2.44% |
| 2010 Q3 | 369.3 Million USD | 3.5% |
| 2010 Q4 | 358.1 Million USD | -3.03% |
| 2009 Q2 | 386.3 Million USD | 0.6% |
| 2009 Q3 | 393 Million USD | 1.73% |
| 2009 Q4 | 379.1 Million USD | -3.54% |
| 2009 Q1 | 384 Million USD | 0.5% |
| 2009 FY | 379.1 Million USD | -0.79% |
| 2008 FY | 382.1 Million USD | -3.17% |
| 2008 Q1 | 417 Million USD | 5.68% |
| 2008 Q3 | 382 Million USD | -3.95% |
| 2008 Q4 | 382.1 Million USD | 0.03% |
| 2008 Q2 | 397.7 Million USD | -4.63% |
| 2007 Q3 | 393.1 Million USD | 2.32% |
| 2007 Q4 | 394.6 Million USD | 0.38% |
| 2007 Q2 | 384.2 Million USD | 2.02% |
| 2007 Q1 | 376.6 Million USD | 59.71% |
| 2007 FY | 394.6 Million USD | 67.35% |
| 2006 Q1 | 270.6 Million USD | -3.6% |
| 2006 Q3 | 240.6 Million USD | -7.21% |
| 2006 Q4 | 235.8 Million USD | -2.0% |
| 2006 FY | 235.8 Million USD | -16.0% |
| 2006 Q2 | 259.3 Million USD | -4.18% |
| 2005 Q1 | 152.7 Million USD | 1.26% |
| 2005 FY | 280.7 Million USD | 86.14% |
| 2005 Q2 | 277.3 Million USD | 81.6% |
| 2005 Q3 | 260.2 Million USD | -6.17% |
| 2005 Q4 | 280.7 Million USD | 7.88% |
| 2004 Q3 | 162.4 Million USD | 6.01% |
| 2004 FY | 150.8 Million USD | -9.7% |
| 2004 Q1 | 148.6 Million USD | -11.02% |
| 2004 Q2 | 153.2 Million USD | 3.1% |
| 2004 Q4 | 150.8 Million USD | -7.14% |
| 2003 Q4 | 167 Million USD | 2.64% |
| 2003 Q2 | 164.1 Million USD | 2.12% |
| 2003 Q3 | 162.7 Million USD | -0.85% |
| 2003 Q1 | 160.7 Million USD | 0.94% |
| 2003 FY | 167 Million USD | 4.9% |
| 2002 Q3 | 172 Million USD | 0.0% |
| 2002 Q2 | 172 Million USD | 0.35% |
| 2002 FY | 159.2 Million USD | -13.62% |
| 2002 Q4 | 159.2 Million USD | -7.44% |
| 2002 Q1 | 171.4 Million USD | -7.0% |
| 2001 Q1 | 195.2 Million USD | -0.31% |
| 2001 Q4 | 184.3 Million USD | -5.68% |
| 2001 FY | 184.3 Million USD | -5.87% |
| 2001 Q3 | 195.4 Million USD | 0.15% |
| 2001 Q2 | 195.1 Million USD | -0.05% |
| 2000 FY | 195.8 Million USD | 38.37% |
| 2000 Q4 | 195.8 Million USD | 1.98% |
| 2000 Q3 | 192 Million USD | 11.24% |
| 2000 Q1 | 130.7 Million USD | -7.63% |
| 2000 Q2 | 172.6 Million USD | 32.06% |
| 1999 FY | 141.5 Million USD | 34.76% |
| 1999 Q3 | 155.4 Million USD | -3.06% |
| 1999 Q4 | 141.5 Million USD | -8.94% |
| 1999 Q2 | 160.3 Million USD | 14.83% |
| 1999 Q1 | 139.6 Million USD | 32.95% |
| 1998 Q1 | 84.9 Million USD | -2.86% |
| 1998 Q2 | 95.2 Million USD | 12.13% |
| 1998 Q3 | 94.9 Million USD | -0.32% |
| 1998 Q4 | 105 Million USD | 10.64% |
| 1998 FY | 105 Million USD | 20.14% |
| 1997 Q3 | 88 Million USD | -1.23% |
| 1997 Q1 | 90.6 Million USD | -5.13% |
| 1997 Q2 | 89.1 Million USD | -1.66% |
| 1997 Q4 | 87.4 Million USD | -0.68% |
| 1997 FY | 87.4 Million USD | -8.48% |
| 1996 FY | 95.5 Million USD | -8.61% |
| 1996 Q4 | 95.5 Million USD | 0.53% |
| 1996 Q1 | 97.9 Million USD | -6.32% |
| 1996 Q3 | 95 Million USD | -11.13% |
| 1996 Q2 | 106.9 Million USD | 9.19% |
| 1995 Q2 | 82.1 Million USD | 14.03% |
| 1995 Q1 | 72 Million USD | 100.56% |
| 1995 Q4 | 104.5 Million USD | -0.95% |
| 1995 FY | 104.5 Million USD | 191.09% |
| 1995 Q3 | 105.5 Million USD | 28.5% |
| 1994 Q2 | 26 Million USD | 3.17% |
| 1994 Q3 | 23.2 Million USD | -10.77% |
| 1994 Q4 | 35.9 Million USD | 54.74% |
| 1994 FY | 35.9 Million USD | 45.93% |
| 1994 Q1 | 25.2 Million USD | 2.44% |
| 1993 Q2 | 32.8 Million USD | 8.61% |
| 1993 FY | 24.6 Million USD | -21.9% |
| 1993 Q4 | 24.6 Million USD | -19.61% |
| 1993 Q3 | 30.6 Million USD | -6.71% |
| 1993 Q1 | 30.2 Million USD | -4.13% |
| 1992 Q2 | 43.7 Million USD | -7.61% |
| 1992 Q4 | 31.5 Million USD | -25.18% |
| 1992 FY | 31.5 Million USD | -35.85% |
| 1992 Q3 | 42.1 Million USD | -3.66% |
| 1992 Q1 | 47.3 Million USD | -3.67% |
| 1991 Q3 | 52.7 Million USD | -1.5% |
| 1991 Q4 | 49.1 Million USD | -6.83% |
| 1991 Q1 | 65.1 Million USD | -1.66% |
| 1991 FY | 49.1 Million USD | -25.83% |
| 1991 Q2 | 53.5 Million USD | -17.82% |
| 1990 Q1 | 56.2 Million USD | 7.87% |
| 1990 Q2 | 60.6 Million USD | 7.83% |
| 1990 Q4 | 66.2 Million USD | -0.6% |
| 1990 Q3 | 66.6 Million USD | 9.9% |
| 1990 FY | 66.2 Million USD | 27.06% |
| 1989 FY | 52.1 Million USD | 6.76% |
| 1989 Q4 | 52.1 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alcon Inc. | 4.59 Billion USD | 96.575% |
| AptarGroup, Inc. | 726.45 Million USD | 78.347% |
| Baxter International Inc. | 11.06 Billion USD | 98.578% |
| Becton, Dickinson and Company | 14.73 Billion USD | 98.933% |
| Bausch + Lomb Corporation | 4.53 Billion USD | 96.529% |
| Haemonetics Corporation | 797.56 Million USD | 80.277% |
| Envista Holdings Corp | 1.5 Billion USD | 89.569% |
| ResMed Inc. | 697.31 Million USD | 77.442% |
| Teleflex Incorporated | 1.83 Billion USD | 91.446% |
| Warby Parker Inc. | 150.17 Million USD | -4.747% |